Shots:

• The US FDA has approved Rezipres for the treatment of hypotension that occurs in the setting of anesthesia
• Rezipres is a sulfite-free formulation that has been sold successfully in the EU for years. Additionally- the company is expected to make it available for US patients shortly
• Currently- the company receives royalties from four FDA-approved products- including Alkindi Sprinkle- Biorphen- Rezipres- and Alaway Preservative Free- and has five additional products that have been submitted to the FDA

| Ref: Globe Newswire | Image: Linkedin